Wildy logo
(020) 7242 5778

Wildy’s Book News

Book News cover photo

Vol 21 No 9 Sept/Oct 2016

Book of the Month

Cover of Goode on Commercial Law

Goode on Commercial Law

Edited by: Ewan McKendrick
Price: £170.00

Pupillage & Student Offers

Special Discounts for Pupils, Newly Called & Students

Read More ...

Secondhand & Out of Print

Browse Secondhand Online


Bioproperty, Biomedicine and Deliberative Governance: Patents as Discourse on Life

Image not available lge

ISBN13: 9780754677383
Published: December 2014
Publisher: Ashgate Publishing Ltd
Country of Publication: UK
Format: Hardback
Price: £95.00

Despatched in 6 to 8 days.

Also available as
+ £15.83 VAT

Biomedical patents have been the subject of heated debate. Regulatory agencies such as the European Patent Office make small decisions with big implications, which escape scrutiny and revision, when they decide who has access to expensive diagnostic tests, whether human embryonic stem cells can be traded in markets, and under what circumstances human health is more important than animal welfare. Moreover, the administration of the Trade Related Aspects of Intellectual Property Rights by the World Trade Organization has raised considerable disquiet as it has arguably created grave health inequities. Those doubting the merits of the one size fits all approach ask whether priority should be given to serving the present needs of populations in dire need of medication or to promoting global innovation.

The book looks in detail into the legal issues and ethical debates to ask the following three main questions: First, what are the ideas, goals, and broader ethical visions that underpin questions of governance and the legal reasoning employed by administrative agencies? Second, how can we democratize the decision making process of technocratic institutions such as the European Patent Office? Finally, how can we make the global intellectual property system more equitable? In answering these questions the book seeks to contribute to our understanding of the role and function of regulatory agencies in the regulation of the bioeconomy, explains the process of interpretation of legal norms, and proposes ways to rethink the reform of the patent system through the lens of legitimacy.

Image not available lge
Intellectual Property Law, Medical Law

Part I The European Patent Office and the Question of Legitimacy: Morality, Ethics, and Technocracy: The European Patent Office, biotechnology and ethics. Revising ends of policy and rethinking public deliberation
Neutral or practically wise regulator? Genes, patents, and human health
Rethinking multilevel governance in the EU and the future of the EPO. From morality to ethics.

Part II The European Patent Office and Public Bioethics: Public bioethics. Lay opinions, human need and the case of germ line interventions in human embryos
EPO and public bioethics. Germ line interventions in human embryos, the problem of commodification and the question of incentives.

Part III Patents, Global Trade and Bioethics. Rethinking Good Governance: TRIPs, access to medicines, and the global governance of patents. Cultivating humanity and equity
Global health networks and discursive legitimacy
Some reflections on good patent governance
Conclusions: a discursive analysis of patents.